Pei‐Chi Kao

459 total citations
28 papers, 230 citations indexed

About

Pei‐Chi Kao is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Pei‐Chi Kao has authored 28 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 7 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Pei‐Chi Kao's work include Neuroblastoma Research and Treatments (9 papers), Glioma Diagnosis and Treatment (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Pei‐Chi Kao is often cited by papers focused on Neuroblastoma Research and Treatments (9 papers), Glioma Diagnosis and Treatment (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Pei‐Chi Kao collaborates with scholars based in United States, Canada and Taiwan. Pei‐Chi Kao's co-authors include Yen‐Hsuan Ni, Jia‐Feng Wu, Mei‐Hwei Chang, Clement Ma, Wendy B. London, Leslie Lehmann, Christine Duncan, Huey‐Ling Chen, Steven Margossian and Hong‐Yuan Hsu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hepatology.

In The Last Decade

Pei‐Chi Kao

23 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pei‐Chi Kao United States 8 75 42 42 41 37 28 230
Gemma Petts United Kingdom 11 85 1.1× 39 0.9× 45 1.1× 41 1.0× 31 0.8× 26 279
Daniel Moya-Rull Spain 9 122 1.6× 36 0.9× 24 0.6× 53 1.3× 23 0.6× 13 258
Navdeep Nayyar United States 8 72 1.0× 28 0.7× 56 1.3× 126 3.1× 10 0.3× 10 339
Mengying Bao China 5 129 1.7× 32 0.8× 40 1.0× 29 0.7× 59 1.6× 7 228
Helmuth Goecke Chile 7 100 1.3× 58 1.4× 26 0.6× 75 1.8× 25 0.7× 20 271
Alix Besançon France 9 35 0.5× 59 1.4× 129 3.1× 65 1.6× 17 0.5× 15 293
Mark T. Vander Lugt United States 6 56 0.7× 42 1.0× 179 4.3× 54 1.3× 41 1.1× 14 381
P Rossi-Ferrini Italy 11 38 0.5× 40 1.0× 38 0.9× 41 1.0× 15 0.4× 19 333
C. F. Lucas United Kingdom 5 31 0.4× 35 0.8× 40 1.0× 26 0.6× 22 0.6× 7 321
Ramdane Belhocine France 9 21 0.3× 67 1.6× 42 1.0× 12 0.3× 17 0.5× 18 223

Countries citing papers authored by Pei‐Chi Kao

Since Specialization
Citations

This map shows the geographic impact of Pei‐Chi Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Chi Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Chi Kao more than expected).

Fields of papers citing papers by Pei‐Chi Kao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei‐Chi Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Chi Kao. The network helps show where Pei‐Chi Kao may publish in the future.

Co-authorship network of co-authors of Pei‐Chi Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Pei‐Chi Kao. A scholar is included among the top collaborators of Pei‐Chi Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei‐Chi Kao. Pei‐Chi Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shulman, David S., Kieuhoa T. Vo, Frank M. Balis, et al.. (2025). A Phase 1 Trial of Fimepinostat in Children and Adolescents With Relapsed and Refractory Solid and CNS Tumors. Cancer Medicine. 14(23). e71417–e71417.
3.
Kao, Pei‐Chi, et al.. (2024). Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric Oncology. Cancer Medicine. 13(24). e70356–e70356.
4.
Wright, Karen, Cassie Kline, Mohamed S Abdelbaki, et al.. (2024). Phase IB study of tovorafenib for children with relapsed/recurrent low-grade gliomas and other MAPK pathway activated tumors.. Journal of Clinical Oncology. 42(16_suppl). 10001–10001. 1 indexed citations
5.
Shulman, David S., Priscilla Merriam, Edwin Choy, et al.. (2023). Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma. Cancer Medicine. 12(14). 15207–15216. 21 indexed citations
6.
Benedetti, Daniel J., et al.. (2023). Tolerability of ifosfamide‐containing regimen in patients with high‐risk renal and INI‐1‐deficient tumors. Pediatric Blood & Cancer. 70(8). e30422–e30422. 3 indexed citations
7.
Schoettler, Michelle Long, Leslie Lehmann, Pei‐Chi Kao, et al.. (2023). Pediatric transplant–associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy. Blood Advances. 8(5). 1220–1233. 1 indexed citations
8.
Kao, Pei‐Chi, Emma Morris, Amy Federico, et al.. (2023). Patient and Parent-Reported Outcomes Post-Treatment with Shmir-Based Lentiviral Gene Therapy for Sickle Cell Disease. Blood. 142(Supplement 1). 3750–3750. 1 indexed citations
9.
Campbell, Kevin, Pei‐Chi Kao, Arlene Naranjo, et al.. (2022). Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. Pediatric Blood & Cancer. 70(2). e30054–e30054. 7 indexed citations
10.
Wright, Karen, Cassie Kline, Mohamed S Abdelbaki, et al.. (2022). CTNI-53. PNOC014: PHASE IB STUDY RESULTS OF DAY101(TOVORAFENIB) FOR CHILDREN WITH LOW-GRADE GLIOMAS (LGGS) AND OTHER RAS/RAF/MEK/ERK PATHWAY-ACTIVATED TUMORS. Neuro-Oncology. 24(Supplement_7). vii84–vii84. 9 indexed citations
11.
London, Wendy B., Hannah Bender, Meredith S. Irwin, et al.. (2022). Survival of patients with neuroblastoma before versus after reduction of therapy due to the change in age cut-off from 12 to 18 months in Children’s Oncology Group (COG) risk stratification.. Journal of Clinical Oncology. 40(16_suppl). 10013–10013.
12.
Shulman, David S., Priscilla Merriam, Edwin Choy, et al.. (2022). Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma.. Journal of Clinical Oncology. 40(16_suppl). e23507–e23507. 3 indexed citations
13.
Kao, Pei‐Chi, Yi‐Ting Tsai, Chi‐Hsiang Chung, et al.. (2022). Hypothyroidism Is Correlated with Ventilator Complications and Longer Hospital Days after Coronary Artery Bypass Grafting Surgery in a Relatively Young Population: A Nationwide, Population-Based Study. Journal of Clinical Medicine. 11(13). 3881–3881. 2 indexed citations
14.
Kao, Pei‐Chi, et al.. (2021). Symptoms and Suffering at End of Life for Children With Complex Chronic Conditions. Journal of Pain and Symptom Management. 63(1). 88–97. 17 indexed citations
15.
Forrest, Suzanne J., Cassie Kline, Thomas F. Cash, et al.. (2021). Phase II study of nivolumab and ipilimumab in children and young adults with INI1-negative cancers.. Journal of Clinical Oncology. 39(15_suppl). TPS10055–TPS10055. 4 indexed citations
16.
Church, Alanna J., Laura Corson, Pei‐Chi Kao, et al.. (2021). Clinical impact of molecular tumor profiling in pediatric, adolescent, and young adult patients with extra-cranial solid malignancies: An interim report from the GAIN/iCat2 study.. Journal of Clinical Oncology. 39(15_suppl). 10005–10005. 2 indexed citations
17.
Hawryluk, Elena B., Pei‐Chi Kao, Wendy B. London, Jennifer T. Huang, & Ashfaq A. Marghoob. (2020). 18420 A retrospective multicenter study of fatal pediatric melanoma. Journal of the American Academy of Dermatology. 83(6). AB99–AB99. 1 indexed citations
18.
Wu, Jia‐Feng, Pei‐Chi Kao, Huey‐Ling Chen, et al.. (2012). A high serum interleukin‐12p40 level prior to Kasai surgery predict a favourable outcome in children with biliary atresia. Liver International. 32(10). 1557–1563. 16 indexed citations
19.
Kao, Pei‐Chi, Jia‐Feng Wu, Yen‐Hsuan Ni, et al.. (2010). Tumour necrosis factor-α promoter region polymorphisms affect the course of spontaneous HBsAg clearance. Liver International. 30(10). 1448–1453. 25 indexed citations
20.
Lin, Yi-Ruu, Pei‐Chi Kao, & Ming‐Huan Chan. (2005). Involvement of Ca2+ signaling in tachykinin-mediated contractile responses in swine trachea. Journal of Biomedical Science. 12(3). 547–558. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gemma Petts Breakdown of academic impact, for papers by Daniel Moya-Rull Breakdown of academic impact, for papers by Navdeep Nayyar Breakdown of academic impact, for papers by Mengying Bao Breakdown of academic impact, for papers by Helmuth Goecke Breakdown of academic impact, for papers by Alix Besançon Breakdown of academic impact, for papers by Mark T. Vander Lugt Breakdown of academic impact, for papers by P Rossi-Ferrini Breakdown of academic impact, for papers by C. F. Lucas Breakdown of academic impact, for papers by Ramdane Belhocine
Rankless by CCL
2026